Noam Nissan1,2, Tanir Allweis3, Tehillah Menes4, Asia Brodsky5, Shani Paluch-Shimon6, Ilana Haas7, Orit Golan8, Yaheli Miller3, Hani Barlev9, Einat Carmon10, Malka Brodsky11, Debbie Anaby11, Philip Lawson11, Osnat Halshtok-Neiman11, Anat Shalmon11, Michael Gotlieb11, Renata Faermann11, Eli Konen11, Miri Sklair-Levy11. 1. Department of Radiology, Sheba Medical Center, Emek Ha-Ella 1 st., 5265601, Tel Hashomer, Israel. noamniss@gmail.com. 2. Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. noamniss@gmail.com. 3. Department of General Surgery, Kaplan Medical Center, Rehovot, Israel. 4. Department of General Surgery, Tel Aviv Souraski Medical Center, Tel Aviv, Israel. 5. Department of General Surgery, Bnai Zion Medical Center, Haifa, Israel. 6. Department of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel. 7. Department of General Surgery, Meir Medical Center, Saba, Israel. 8. Department of Radiology, Tel Aviv Souraski Medical Center, Tel Aviv, Israel. 9. Department of General Surgery, Laniado Medical Center, Netanya, Israel. 10. Department of General Surgery, Hadassah Medical Center, Jerusalem, Israel. 11. Department of Radiology, Sheba Medical Center, Emek Ha-Ella 1 st., 5265601, Tel Hashomer, Israel.
Abstract
PURPOSE: To investigate the effect of lactation on breast cancer conspicuity on dynamic contrast-enhanced (DCE) MRI in comparison with diffusion tensor imaging (DTI) parametric maps. MATERIALS AND METHODS: Eleven lactating patients with 16 biopsy-confirmed pregnancy-associated breast cancer (PABC) lesions were prospectively evaluated by DCE and DTI on a 1.5-T MRI for pre-treatment evaluation. Additionally, DCE datasets of 16 non-lactating age-matched breast cancer patients were retrospectively reviewed, as control. Contrast-to-noise ratio (CNR) comprising two regions of interests of the normal parenchyma was used to assess the differences in the tumor conspicuity on DCE subtraction images between lactating and non-lactating patients, as well as in comparison against DTI parametric maps of λ1, λ2, λ3, mean diffusivity (MD), fractional anisotropy (FA), and maximal anisotropy index, λ1-λ3. RESULTS: CNR values of breast cancer on DCE MRI among lactating patients were reduced by 62% and 58% (p < 0.001) in comparison with those in non-lactating patients, when taking into account the normal contralateral parenchyma and an area of marked background parenchymal enhancement (BPE), respectively. Among the lactating patients, DTI parameters of λ1, λ2, λ3, MD, and λ1-λ3 were significantly decreased, and FA was significantly increased in PABC, relative to the normal lactating parenchyma ROIs. When compared against DCE in the lactating cohort, the CNR on λ1, λ2, λ3, and MD was significantly superior, providing up to 138% more tumor conspicuity, on average. CONCLUSION: Breast cancer conspicuity on DCE MRI is markedly reduced during lactation owing to the marked BPE. However, the additional application of DTI can improve the visualization and quantitative characterization of PABC, therefore possibly suggesting an additive value in the diagnostic workup of PABC. KEY POINTS: • Breast cancer conspicuity on DCE MRI has decreased by approximately 60% among lactating patients compared with non-lactating controls. • DTI-derived diffusion coefficients and the anisotropy indices of PABC lesions were significantly different than those of the normal lactating fibroglandular tissue. • Among lactating patients, breast cancer conspicuity on DTI-derived parametric maps provided up to 138% increase in contrast-to-noise ratio compared with DCE imaging.
PURPOSE: To investigate the effect of lactation on breast cancer conspicuity on dynamic contrast-enhanced (DCE) MRI in comparison with diffusion tensor imaging (DTI) parametric maps. MATERIALS AND METHODS: Eleven lactating patients with 16 biopsy-confirmed pregnancy-associated breast cancer (PABC) lesions were prospectively evaluated by DCE and DTI on a 1.5-T MRI for pre-treatment evaluation. Additionally, DCE datasets of 16 non-lactating age-matched breast cancerpatients were retrospectively reviewed, as control. Contrast-to-noise ratio (CNR) comprising two regions of interests of the normal parenchyma was used to assess the differences in the tumor conspicuity on DCE subtraction images between lactating and non-lactating patients, as well as in comparison against DTI parametric maps of λ1, λ2, λ3, mean diffusivity (MD), fractional anisotropy (FA), and maximal anisotropy index, λ1-λ3. RESULTS: CNR values of breast cancer on DCE MRI among lactating patients were reduced by 62% and 58% (p < 0.001) in comparison with those in non-lactating patients, when taking into account the normal contralateral parenchyma and an area of marked background parenchymal enhancement (BPE), respectively. Among the lactating patients, DTI parameters of λ1, λ2, λ3, MD, and λ1-λ3 were significantly decreased, and FA was significantly increased in PABC, relative to the normal lactating parenchyma ROIs. When compared against DCE in the lactating cohort, the CNR on λ1, λ2, λ3, and MD was significantly superior, providing up to 138% more tumor conspicuity, on average. CONCLUSION:Breast cancer conspicuity on DCE MRI is markedly reduced during lactation owing to the marked BPE. However, the additional application of DTI can improve the visualization and quantitative characterization of PABC, therefore possibly suggesting an additive value in the diagnostic workup of PABC. KEY POINTS: • Breast cancer conspicuity on DCE MRI has decreased by approximately 60% among lactating patients compared with non-lactating controls. • DTI-derived diffusion coefficients and the anisotropy indices of PABC lesions were significantly different than those of the normal lactating fibroglandular tissue. • Among lactating patients, breast cancer conspicuity on DTI-derived parametric maps provided up to 138% increase in contrast-to-noise ratio compared with DCE imaging.
Entities:
Keywords:
Breast; Breastfeeding; Diffusion; Lactating; Magnetic resonance imaging
Authors: Pascal A T Baltzer; Anja Schäfer; Matthias Dietzel; David Grässel; Mieczyslaw Gajda; Oumar Camara; Werner A Kaiser Journal: Eur Radiol Date: 2010-07-29 Impact factor: 5.315
Authors: Savannah C Partridge; Revathi S Murthy; Ali Ziadloo; Steven W White; Kimberly H Allison; Constance D Lehman Journal: Magn Reson Imaging Date: 2010-01-12 Impact factor: 2.546
Authors: Savannah C Partridge; Ali Ziadloo; Revathi Murthy; Steven W White; Sue Peacock; Peter R Eby; Wendy B DeMartini; Constance D Lehman Journal: J Magn Reson Imaging Date: 2010-02 Impact factor: 4.813
Authors: Ashley M Mendez; Lauren K Fang; Claire H Meriwether; Summer J Batasin; Stéphane Loubrie; Ana E Rodríguez-Soto; Rebecca A Rakow-Penner Journal: Front Oncol Date: 2022-07-08 Impact factor: 5.738